Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Sci Rep ; 11(1): 10452, 2021 05 17.
Artigo em Inglês | MEDLINE | ID: mdl-34001919

RESUMO

MicroRNAs are non-coding RNAs that act to downregulate the expression of target genes by translational repression and degradation of messenger RNA molecules. Individual microRNAs have the ability to specifically target a wide array of gene transcripts, therefore allowing each microRNA to play key roles in multiple biological pathways. miR-324 is a microRNA predicted to target thousands of RNA transcripts and is expressed far more highly in the brain than in any other tissue, suggesting that it may play a role in one or multiple neurological pathways. Here we present data from the first global miR-324-null mice, in which increased excitability and interictal discharges were identified in vitro in the hippocampus. RNA sequencing was used to identify differentially expressed genes in miR-324-null mice which may contribute to this increased hippocampal excitability, and 3'UTR luciferase assays and western blotting revealed that two of these, Suox and Cd300lf, are novel direct targets of miR-324. Characterisation of microRNAs that produce an effect on neurological activity, such as miR-324, and identification of the pathways they regulate will allow a better understanding of the processes involved in normal neurological function and in turn may present novel pharmaceutical targets in treating neurological disease.


Assuntos
Excitabilidade Cortical/genética , Hipocampo/fisiologia , MicroRNAs/metabolismo , Oxirredutases atuantes sobre Doadores de Grupo Enxofre/genética , Receptores Imunológicos/genética , Animais , Linhagem Celular , Feminino , Masculino , Camundongos , Camundongos Knockout , MicroRNAs/genética , Neocórtex/fisiologia , RNA-Seq , Transdução de Sinais/genética
2.
Neuropharmacology ; 158: 107728, 2019 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-31356824

RESUMO

The RISE model is an effective system to study the underlying molecular and cellular mechanisms involved in the initiation and maintenance of epilepsy in vivo. Here we profiled the expression of excitatory and inhibitory neurotransmitter receptor subunits and synaptic scaffolding proteins in the hippocampus and temporal lobe and compared these changes with alterations in network activity at specific timepoints during epileptogenesis. Significant changes occurred in all of the ionotropic glutamate receptor subunits tested during epilepsy induction and progression and the profile of these changes differed between the hippocampus and temporal lobe. Notably, AMPAR subunits were dramatically decreased during the latent phase of epilepsy induction, matched by a profound decrease in the network response to kainate application in the hippocampus. Moreover, decreases in the GABAAß3 subunit are consistent with a loss of inhibitory input contributing to the perturbation of excitatory/inhibitory balance and seizure generation. These data highlight the synaptic reorganisation that mediates the relative hypoexcitability prior to the manifestation of seizures and subsequent hyperexcitability when spontaneous seizures develop. These patterns of changes give new insight into the mechanisms underpinning epilepsy and provide a platform for future investigations targeting particular receptor subunits to reduce or prevent seizures.


Assuntos
Epilepsia/metabolismo , Hipocampo/metabolismo , Receptores de GABA-A/metabolismo , Receptores de Glutamato/metabolismo , Estado Epiléptico/metabolismo , Sinapses/metabolismo , Lobo Temporal/metabolismo , Animais , Modelos Animais de Doenças , Epilepsia/induzido quimicamente , Agonistas Muscarínicos/toxicidade , Pilocarpina/toxicidade , Ratos , Receptores de AMPA/metabolismo , Receptores de Ácido Caínico/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Estado Epiléptico/induzido quimicamente , Receptor de GluK2 Cainato
3.
PLoS One ; 11(2): e0147265, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26909803

RESUMO

Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and establishment of the disorder. Typically, following a systemic or local insult, vulnerable brain regions undergo a process leading to the development, over time, of spontaneous recurrent seizures. Many such models make use of a period of intense seizure activity or status epilepticus, and this may be associated with high mortality and/or global damage to large areas of the brain. These undesirable elements have driven improvements in the design of chronic epilepsy models, for example the lithium-pilocarpine epileptogenesis model. Here, we present an optimised model of chronic epilepsy that reduces mortality to 1% whilst retaining features of high epileptogenicity and development of spontaneous seizures. Using local field potential recordings from hippocampus in vitro as a probe, we show that the model does not result in significant loss of neuronal network function in area CA3 and, instead, subtle alterations in network dynamics appear during a process of epileptogenesis, which eventually leads to a chronic seizure state. The model's features of very low mortality and high morbidity in the absence of global neuronal damage offer the chance to explore the processes underlying epileptogenesis in detail, in a population of animals not defined by their resistance to seizures, whilst acknowledging and being driven by the 3Rs (Replacement, Refinement and Reduction of animal use in scientific procedures) principles.


Assuntos
Modelos Animais de Doenças , Estado Epiléptico/epidemiologia , Animais , Comportamento Animal , Progressão da Doença , Humanos , Masculino , Morbidade , Ratos , Ratos Wistar , Recidiva , Estado Epiléptico/mortalidade , Estado Epiléptico/patologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa